Bicycle therapeutics to participate in upcoming virtual investor conferences

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that management will participate in the following virtual investor conferences in june: jefferies virtual healthcare conference on thursday, june 3, 2021; fireside chat at 11:00 a.m. et goldman sachs 42nd annual global healthcare conference on tuesd
BCYC Ratings Summary
BCYC Quant Ranking